Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $674.25M | $650.77M | $604.08M | $572.94M | $542.50M | $540.60M | $542.74M | $523.81M |
| Cost of revenue | $524.84M | $512.17M | $480.29M | $454.53M | $426.29M | $432.42M | $430.57M | $417.13M |
| Gross profit | $149.41M | $138.60M | $123.79M | $118.41M | $116.22M | $108.18M | $112.17M | $106.69M |
| Gross margin | 22.2% | 21.3% | 20.5% | 20.7% | 21.4% | 20.0% | 20.7% | 20.4% |
| Selling, general and administrative | $19.89M | $17.61M | $16.53M | $14.11M | $14.94M | $13.16M | $12.06M | $11.92M |
| Operating expenses | $106.98M | $100.16M | $87.35M | $75.93M | $69.80M | $91.46M | $72.83M | $72.85M |
| Operating income | $42.44M | $38.45M | $36.43M | $42.48M | $46.42M | $16.73M | $39.34M | $33.83M |
| Operating margin | 6.3% | 5.9% | 6.0% | 7.4% | 8.6% | 3.1% | 7.2% | 6.5% |
| EBITDA | $108.42M | $116.83M | $103.94M | $101.25M | $78.47M | $91.20M | $97.21M | $91.27M |
| Interest income | $1.91M | $2.34M | $3.49M | $2.31M | $1.48M | $1.53M | $4.25M | $2.14M |
| Interest expense | −$18.63M | −$18.80M | −$19.81M | −$20.39M | −$22.63M | −$22.95M | −$30.30M | −$30.40M |
| Income before taxes | $30.98M | $23.49M | $8.53M | $35.55M | $10.81M | −$6.24M | −$31.94M | −$2.83M |
| Income taxes | −$3.00K | −$525.00K | −$2.42M | −$21.09M | $732.00K | $604.00K | $486.00K | $263.00K |
| Net income | $30.98M | $24.01M | $10.94M | $56.64M | $10.08M | −$6.84M | −$32.43M | −$3.09M |
| Net margin | 4.6% | 3.7% | 1.8% | 9.9% | 1.9% | -1.3% | -6.0% | -0.6% |
| EPS, basic | $0.16 | $0.13 | $0.06 | $0.33 | $0.06 | −$0.04 | −$0.21 | −$0.03 |
| EPS, diluted | $0.16 | $0.13 | $0.06 | $0.33 | $0.06 | −$0.04 | −$0.21 | −$0.03 |
| Diluted shares | 193.35M | 187.97M | 179.53M | 169.80M | 161.14M | 156.92M | 153.83M | 133.73M |
Figures describe American Healthcare REIT shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.